General introduction 31 89. van der Baan FH, Koldenhof J J, de Nijs EJ, et al. Validation of the Dutch version of the Edmonton Symptom Assessment System. Cancer Med 2020 2020/07/10. DOI: 10.1002/ cam4.3253. 90. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778. 1987/10/01. DOI: 10.1136/thx.42.10.773. 91. van Kessel P, Hendriks M, van der Hoek L, et al. Ontwikkeling van de Care Related Quality of Life voor Chronisch Hartfalen (CaReQoL CHF). Een vragenlijst voor het meten van de ervaren uitkomsten van chronische zorg. 2015. NIVEL. 92. Peters LL, Boter H, Buskens E, et al. Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. J Am Med Dir Assoc 2012; 13: 546-551. 2012/05/15. DOI: 10.1016/j.jamda.2012.04.007. 93. Bellera CA, Rainfray M, Mathoulin-Pelissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012; 23: 2166-2172. 2012/01/18. DOI: 10.1093/annonc/mdr587. 94. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7: 6-9. 1991/01/01. 95. Hui D and Bruera E. The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments. J Pain Symptom Manage 2017; 53: 630-643. 2017/01/04. DOI: 10.1016/j.jpainsymman.2016.10.370. 96. Oldenmenger WH, de Raaf PJ, de Klerk C, et al. Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage 2013; 45: 1083-1093. 2012/09/29. DOI: 10.1016/j. jpainsymman.2012.06.007. 97. Hui D, Shamieh O, Paiva CE, et al. Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer 2015; 121: 3027-3035. 2015/06/11. DOI: 10.1002/cncr.29437. 98. Bedard G, Zeng L, Zhang L, et al. Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer. J Pain Symptom Manage 2013; 46: 192-200. 2012/11/28. DOI: 10.1016/j.jpainsymman.2012.07.022. 99. de Vries S, Lormans T, de Graaf E, et al. The content validity of the items related to the social and spiritual dimensions of the Utrecht Symptom Diary - 4 Dimensional from a patient ’s perspective: a qualitative study. J Pain Symptom Manage 2020 2020/08/11. DOI: 10.1016/j. jpainsymman.2020.07.036. 100. Leget C. Art of living, art of dying. Jessica Kingsley Publishers, London/Philadelphia, 2017. 101. Osse BH, Vernooij-Dassen MJ, Schade E, et al. The problems experienced by patients with cancer and their needs for palliative care. Support Care Cancer 2005; 13: 722-732. 2005/02/11. DOI: 10.1007/s00520-004-0771-6. 102. Kirk P, Kirk I and Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ 2004; 328: 1343. 2004/05/21. DOI: 10.1136/bmj.38103.423576.55. 103. Parker SM, Clayton JM, Hancock K, et al. A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/ caregiver preferences for the content, style, and timing of information. J Pain Symptom Manage 2007; 34: 81-93. 2007/05/29. DOI: 10.1016/j.jpainsymman.2006.09.035. 104. Hui D, Paiva CE, Del Fabbro EG, et al. Prognostication in advanced cancer: update and directions for future research. Support Care Cancer 2019; 27: 1973-1984. 2019/03/14. DOI: 10.1007/s00520-019-04727-y. 105. van der Zwaard, Francke A and Gamel C. Informatiebehoeften van patiënten die palliatieve zorg ontvangen en hun naasten: Een literatuurstudie. Verpleegkunde 2003; 18: 8-20. 1
RkJQdWJsaXNoZXIy MTk4NDMw